Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 21;16(6):243-8.
doi: 10.1186/2047-783x-16-6-243.

Induction maintenance concept for HAART as initial treatment in HIV infected infants

Sujal Ghosh  1 , J Neubert, T Niehues, O Adams, N Morali-Karzei, A Borkhardt, H J Laws
Affiliations

Induction maintenance concept for HAART as initial treatment in HIV infected infants

Sujal Ghosh et al. Eur J Med Res. .

Abstract

Background: Early initiated antiretroviral therapy (ART) in HIV infected infants leads to improved long-term viral suppression and survival. Guidelines recommend initiating therapy with a triple ART consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either one additional non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI). Compared to older children and adults, viral relapse is seen more frequently in infants receiving triple ART. We now address the possibility of a more potent ART with a quadruple induction and triple maintenance therapy.

Methods: We examine the longitudinal course in four HIV infected infants, who were referred from other centers and could not be recruited to multicentre trials. We introduced ART initially consisting of two NRTIs, one NNRTI and one PI and later discontinued the PI at the age of 12 months maintaining a triple regime consisting of two NRTIs and one NNRTI.

Results: Provided that therapy adherence was maintained we observed an effective sustained decline of viral load and significant CD4 cell reconstitution even after switching to a triple regime. No drug associated toxicity was seen.

Conclusion: We suggest that a four drug therapy might be a possible initial therapy option in HIV infected infants, at least in those with a high viral load, followed by a maintenance triple regime after 12 months of therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Peripheral blood viral load (copies/ml) and CD4 count (age related percentage) over time in infants with antiretroviral therapy. The upper horizontal bars show the quadruple and triple drug regime of each patient over time. The horizontal dotted line in each graph represents 100% of age related CD4 cells.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Welch S, Sharland M, Lyall EG, Tudor-Williams G, Niehues T, Wintergerst U. et al.PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV medicine. 2009;10(10):591–613. - PubMed
    1. Children WGoATaMMoH-I. Guidelines for the Use of Antiretroviral Agents in Pediatric. HIV Infection. 2009. pp. 1–139.
    1. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA. et al.Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233–44. doi: 10.1056/NEJMoa0800971. - DOI - PMC - PubMed
    1. Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A. et al.Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS (London, England) 2009;23(5):597–604. doi: 10.1097/QAD.0b013e328326ca37. - DOI - PubMed
    1. PENPACT-1 First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet infectious diseases. Jan 31. - PMC - PubMed

Publication types